The obtained FOXM1-Apt could be used as a probe for FOXM1 detection and an inhibitor of FOXM1 transcriptional function in cancer cells at the same time, providing a potential reagent for cancer diagnosis and therapy in the future. This evidence concerns the gene FOXM1 and cancer.